The Legend Holdings, Kangji Medical and Poly Group-backed surgical robotic arm developer raised the cash in a series C round co-led by Boyu Capital, Temasek and Sequoia Capital China.
Edge Medical Robotics, the China-based robotic surgical technology developer backed by corporates Kangji Medical, Legend Holdings and Poly Group, has secured $200m in series C funding, DealStreetAsia reported yesterday.
Boyu Capital, Temasek and Sequoia Capital China co-led the round, which also featured OrbiMed, Octagon Capital, Sage Partners, Greater Bay Area Homeland Investments, Mirae Asset, Lyfe Capital, 3H Health Investment and Guoce Capital.
Edge Medical provides a range of surgical equipment, including a robotic arm, for use in multi-port laparoscopic surgery.…
